產(chǎn)品描述: | CX-6258 is a potent and kinase selective pan-Pim kinases inhibitor, with IC50s of 5 nM, 25 nM and 16 nM for Pim-1, Pim-2 and Pim-3, respectively |
靶點: |
IC50: 5 nM (Pim-1), 25 nM (Pim-2), 16 nM (Pim-3);Pim |
體內(nèi)研究: |
CX-6258 (50-100 mg/kg; p.o; daily; over a period of 21 days) exhibits robust in vivo efficacy in two Pim kinases driven tumor models |
參考文獻: |
1. Mustapha Haddach, Jerome Michaux, Michael K, Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor. ACS Med. Chem. Lett., 2012, 3 (2), pp 135-139 2. Padmanabhan A, Gosc EB, Bieberich CJ. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells. J Cell Biochem. 2013 May;114(5):1050-7. |
溶解性: |
DMSO : ≥ 50 mg/mL (108.24 mM) |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.165 ml |
10.824 ml |
21.648 ml |
5 mM |
0.433 ml |
2.165 ml |
4.33 ml |
10 mM |
0.216 ml |
1.082 ml |
2.165 ml |
50 mM |
0.043 ml |
0.216 ml |
0.433 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |